TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development

Figure 3 TP53 ⁷²Arg/Pro polymorphism distribution in non-inflammatory bowel disease controls in different countries and comparison to controls utilized in this study (mainly of Eastern European descent). References for indicated bar graphs: Slovak Republic[55], Sweden[30]; Italy[41], Germany[33], Greece[32], Turkey[36], Caucasians/United States[40], Pakistan[56], India[57], Iran[34], China[58], Japan[38], Malaysia[35], South Korea[39], Brazil[59], Argentina[31].